These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 31719824)
21. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. Ostapchenko VG; Beraldo FH; Guimarães AL; Mishra S; Guzman M; Fan J; Martins VR; Prado VF; Prado MA J Neurochem; 2013 Nov; 127(3):415-25. PubMed ID: 23651058 [TBL] [Abstract][Full Text] [Related]
22. Clinical potential of GABAB receptor modulators. Ong J; Kerr DI CNS Drug Rev; 2005; 11(3):317-34. PubMed ID: 16389296 [TBL] [Abstract][Full Text] [Related]
23. Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease. Zhang X; Lao K; Qiu Z; Rahman MS; Zhang Y; Gou X J Alzheimers Dis; 2019; 67(4):1109-1122. PubMed ID: 30741675 [TBL] [Abstract][Full Text] [Related]
24. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice. Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918 [TBL] [Abstract][Full Text] [Related]
25. Increased Calcium-Sensing Receptor Immunoreactivity in the Hippocampus of a Triple Transgenic Mouse Model of Alzheimer's Disease. Gardenal E; Chiarini A; Armato U; Dal Prà I; Verkhratsky A; Rodríguez JJ Front Neurosci; 2017; 11():81. PubMed ID: 28261055 [TBL] [Abstract][Full Text] [Related]
26. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
27. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884 [TBL] [Abstract][Full Text] [Related]
28. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review. Ariga T; Miyatake T; Yu RK J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617 [TBL] [Abstract][Full Text] [Related]
30. Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals. Kim SH; Fraser PE; Westaway D; St George-Hyslop PH; Ehrlich ME; Gandy S J Neurosci; 2010 Mar; 30(11):3870-5. PubMed ID: 20237257 [TBL] [Abstract][Full Text] [Related]
32. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Maccioni RB; Muñoz JP; Barbeito L Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751 [TBL] [Abstract][Full Text] [Related]
34. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans. Wang C; Saar V; Leung KL; Chen L; Wong G Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592 [TBL] [Abstract][Full Text] [Related]
35. Heteroreceptor Complexes Formed by Dopamine D Rodríguez-Ruiz M; Moreno E; Moreno-Delgado D; Navarro G; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Franco R Mol Neurobiol; 2017 Aug; 54(6):4537-4550. PubMed ID: 27370794 [TBL] [Abstract][Full Text] [Related]
36. Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease? Dal Prà I; Chiarini A; Gui L; Chakravarthy B; Pacchiana R; Gardenal E; Whitfield JF; Armato U Neuroscientist; 2015 Feb; 21(1):9-29. PubMed ID: 24740577 [TBL] [Abstract][Full Text] [Related]
37. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674 [TBL] [Abstract][Full Text] [Related]
38. α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction. Chen Y; Peng Y; Che P; Gannon M; Liu Y; Li L; Bu G; van Groen T; Jiao K; Wang Q Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17296-301. PubMed ID: 25404298 [TBL] [Abstract][Full Text] [Related]
39. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples. Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177 [TBL] [Abstract][Full Text] [Related]